Teladoc Health (TDOC.US) saw its stock price rise over 9% on Friday, reaching $9.398 at the time of writing. Several major Wall Street firms have updated their ratings for Teladoc Health, setting target prices between $9 and $12. Notably, Bank of America analyst Allen Lutz maintained a 'Hold' rating and raised the target price from $8.50 to $9.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.